Autoimmune mechanisms underlying dilated cardiomyopathy.
about
Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathyPeripartum cardiomyopathy: A puzzle closer to solution.Peripartum cardiomyopathy: challenges in diagnosis and management.Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.The non-cardiac use and significance of cardiac troponins.Animal models of cardiac disease and stem cell therapy.Troponin and anti-troponin autoantibody levels in patients with ventricular noncompaction.Measurement of antibody effects on cellular function of isolated cardiomyocytes.Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseasesAutoantibodies and cardiac arrhythmias.Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?Calcium channel autoantibodies predicted sudden cardiac death and all-cause mortality in patients with ischemic and nonischemic chronic heart failureThe clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease.The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart functionThe use of therapeutic apheresis in cardiovascular disease.Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy.Current insights into LMNA cardiomyopathies: Existing models and missing LINCsPeptide sharing between Bordetella pertussis proteome and human sudden death proteins: a hypothesis for a causal link.CD4+/CD25+ T-Lymphocytes and Th1/Th2 regulation in dilated cardiomyopathy.Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy.Anti-KCNQ1 K⁺ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy.β1 -Adrenoceptor autoantibodies increase the susceptibility to ventricular arrhythmias involving abnormal repolarization in guinea-pigs.Myocardial oedema in acute myocarditis detected by echocardiographic 2D myocardial deformation analysis.Agonist-like autoantibodies against calcium channel in patients with dilated cardiomyopathy.Cardiac Autoantibody Levels Predict Recurrence Following Cryoballoon-Based Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation Patients.Outcomes of plasma exchange for severe dilated cardiomyopathy in children.Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.
P2860
Q27000434-83DAD83B-E23C-4440-8D62-23C238EE2802Q33358118-29CFAEE4-EDD8-4B03-9884-69AFB979155BQ33363307-5DFE8F04-0B29-4120-AE82-49D95F20F4E4Q33711320-A5ACBBA9-2213-4D1E-AA90-12A2F92093A3Q34425048-6BFB0351-E9E8-42DF-B45D-3F9F4E1C18ADQ34508351-86A1166F-5F7C-4BF3-AE3E-479707723A8DQ34612297-0EF5096C-148E-4B2B-913F-6FDBDEB7A4B8Q34633417-E4C2AC76-B6F4-4313-A764-550B7821CFC5Q36154780-AEE806A2-FB52-43EF-BA59-219B7D34DE80Q37374540-693A1E47-E299-487D-9566-9D578C1A8A83Q37608333-5987D259-39CC-42AC-AE51-498B8108FDC3Q37664467-D42BD723-2AB8-4E70-84E3-2209C781F7A7Q37824303-7F088D14-621E-4151-81DB-7E88F02337BCQ37826112-51384A6E-9EC2-42FE-8C83-1E92613EB41BQ37973384-3BEDF1DE-D9BF-4441-BCC4-9D529E21E2DFQ38203567-E899251D-64D0-4B67-BE86-B6EFA3E48ACFQ38717697-9B89C687-9F80-4A70-826D-63F09D9F3353Q39104972-6AC9368A-EDAA-4A67-B588-841118C05B55Q39375013-E69ABE90-C465-48BB-909B-D04749F0DA9FQ42767808-CBD97810-8750-45B8-828E-EF5744AC4757Q45325142-E8BAE59C-05C9-46F4-B922-AA265643CF49Q46670824-79D79586-EEB9-43A4-9974-2090ECEDF59AQ46845228-EAF5AB2B-BE9D-41CE-8E03-7A1463E3039DQ48641304-BB981C0F-41FF-4B51-8C15-2E9849E25FD2Q48667280-C033324E-C930-4A02-815C-D4443D0A3059Q51042604-61C5790D-43E1-4586-A4AA-E55672320308Q51354832-B39C58B9-7D8E-4790-9B91-7040A6FFD78EQ55166882-9D584D45-E227-41B1-90A5-9F7E5FE8ACF7
P2860
Autoimmune mechanisms underlying dilated cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoimmune mechanisms underlying dilated cardiomyopathy.
@en
Autoimmune mechanisms underlying dilated cardiomyopathy.
@nl
type
label
Autoimmune mechanisms underlying dilated cardiomyopathy.
@en
Autoimmune mechanisms underlying dilated cardiomyopathy.
@nl
prefLabel
Autoimmune mechanisms underlying dilated cardiomyopathy.
@en
Autoimmune mechanisms underlying dilated cardiomyopathy.
@nl
P356
P1433
P1476
Autoimmune mechanisms underlying dilated cardiomyopathy
@en
P2093
Akiyasu Baba
Tsutomu Yoshikawa
P304
P356
10.1253/CIRCJ.CJ-08-1151
P577
2009-02-26T00:00:00Z